9643 related articles for article (PubMed ID: 14567031)
21. Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis.
Salvatorelli E; De Tursi M; Menna P; Carella C; Massari R; Colasante A; Iacobelli S; Minotti G
Drug Metab Dispos; 2012 Dec; 40(12):2365-73. PubMed ID: 22972909
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis.
Cashin PH; Ehrsson H; Wallin I; Nygren P; Mahteme H
Eur J Clin Pharmacol; 2013 Mar; 69(3):533-40. PubMed ID: 22983312
[TBL] [Abstract][Full Text] [Related]
23. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.
Sugarbaker PH; Chang D
Eur J Surg Oncol; 2017 Jul; 43(7):1228-1235. PubMed ID: 28189456
[TBL] [Abstract][Full Text] [Related]
24. [Peritonectomy and intraperitoneal chemotherapy--new methods in multi-modality therapy of peritoneal carcinosis].
Jähne J; Piso P
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1435-7. PubMed ID: 9931904
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis.
Sugarbaker PH
Dis Colon Rectum; 1994 Feb; 37(2 Suppl):S115-22. PubMed ID: 8313782
[TBL] [Abstract][Full Text] [Related]
26. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma.
Pilati P; Mocellin S; Rossi CR; Foletto M; Campana L; Nitti D; Lise M
Ann Surg Oncol; 2003 Jun; 10(5):508-13. PubMed ID: 12794016
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
[TBL] [Abstract][Full Text] [Related]
28. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
[TBL] [Abstract][Full Text] [Related]
29. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: initial experience in Oaxaca, Mexico.
García-Matus R; Hernández-Hernández CA; Leyva-García O; Vásquez-Ciriaco S; Flores-Ayala G; Navarro-Hernández Q; Pérez-Bustamante G; Valencia-Mijares NM; Esquivel J
Am Surg; 2012 Sep; 78(9):942-6. PubMed ID: 22964201
[TBL] [Abstract][Full Text] [Related]
30. Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kusamura S; Baratti D; Antonucci A; Younan R; Laterza B; Oliva GD; Gavazzi C; Deraco M
Ann Surg Oncol; 2007 Dec; 14(12):3443-52. PubMed ID: 17909918
[TBL] [Abstract][Full Text] [Related]
31. [Resectional treatment of peritoneal carcinomatosis followed by intraperitoneal chemotherapy, practical aspects].
Elias D; Lasser P; Reynard B; Ducreux M; Pocard M
J Chir (Paris); 2003 Oct; 140(5):270-6. PubMed ID: 14631291
[TBL] [Abstract][Full Text] [Related]
32. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
33. Management of peritoneal surface malignancy. Preface.
Sugarbaker PH
Surg Oncol Clin N Am; 2003 Jul; 12(3):xxi-xxiv. PubMed ID: 14567015
[No Abstract] [Full Text] [Related]
34. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP).
Park BJ; Alexander HR; Libutti SK; Wu P; Royalty D; Kranda KC; Bartlett DL
Ann Surg Oncol; 1999 Sep; 6(6):582-90. PubMed ID: 10493628
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer.
Ansaloni L; Agnoletti V; Amadori A; Catena F; Cavaliere D; Coccolini F; De Iaco P; Di Battista M; Framarini M; Gazzotti F; Ghermandi C; Kopf B; Saponara M; Tauceri F; Vallicelli C; Verdecchia GM; Pinna AD
Int J Gynecol Cancer; 2012 Jun; 22(5):778-85. PubMed ID: 22572845
[TBL] [Abstract][Full Text] [Related]
36. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics.
de Lima Vazquez V; Stuart OA; Mohamed F; Sugarbaker PH
Cancer Chemother Pharmacol; 2003 Aug; 52(2):108-12. PubMed ID: 12759776
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
Legendre H; Delaunoit T; Chassaing C; Pector JC
Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
[TBL] [Abstract][Full Text] [Related]
38. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
39. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis.
Bartlett DL; Buell JF; Libutti SK; Reed E; Lee KB; Figg WD; Venzon DJ; Alexander HR
Cancer; 1998 Sep; 83(6):1251-61. PubMed ID: 9740093
[TBL] [Abstract][Full Text] [Related]
40. The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R
J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
